Peptide Vaccination With PD-L1 and PD-L2 Peptides in Untreated Chronic Lymphatic Leukemia.
Clinical trial NCT03939234 · COMPLETED
Trial details
- NCT number
- NCT03939234
- Sponsor
- Lars Møller Pedersen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2021-03-15
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.